Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEIH.L Regulatory News (EIH)

  • There is currently no data for EIH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment in EIF

7 Jun 2007 09:00

Evolvence India Holdings PLC07 June 2007 7 June 2007 Evolvence India Holdings Announces Completion of its Subscription to Evolvence India Fund Approximately US$ 40 million invested into Evolvence India Fund, a private equity fund of funds focusing on growth capital in India Evolvence India Holdings Plc ("EIH" or "the Company"), a fund of funds holdingcompany that focuses on India, today announced that it has completed investingapproximately US$ 40 million of the net offering proceeds raised through itsinitial public offering of common stock into the Evolvence India Fund (EIF), anestablished private equity fund of funds focusing on growth capital in India. Evolvence India Holding raised US$ 65 million at the time of its admission toAIM on 23 March 2007, and has invested approximately $ 40 million of the fundsraised into EIF. This gives investors an opportunity to participate in adiversified portfolio of Indian companies through underlying private equityfunds held by EIF. To date, EIF's portfolio includes investments in sevenprivate equity funds including Baring India Private Equity Fund II, IDFC PrivateEquity Fund II, India Value Fund II, Leverage India Fund, New York LifeInvestment Management India Fund, Ascent India Fund and JM Financial India Fund.EIF has also made five co-investments, to date, and is on course to generatesuperior returns. "This transaction offers great value to our shareholders and represents anendorsement of the commitments made at the time of our IPO," said JayJegannathan, CEO, Evolvence India Holdings. "We intend to provide long termvalue for our shareholders with this capital deployment. EIH provides investorswith the ability to participate in the Indian growth story through a diversifiedprivate equity portfolio without the usual barriers associated with directprivate equity investments." Launched in June 2005, the Evolvence India Fund (EIF) is the first independentprivate equity fund of funds set up for investments into India. The fundprimarily focuses on investments in private equity across all sectors, includingfinancial services, hospitality and infrastructure development. EIF has investeddirectly and through its underlying funds in 69 companies in high growth sectorsin India. EIH believes private equity offers an attractive way of leveraging on India'sgrowth story. The Indian economy is among the fastest growing economies in theworld, with an average GDP growth of over six per cent per annum over the lastten years and the Asian Development Bank expects the Indian economy to continueto grow over the next decade. Private equity investments in India in 2006amounted to approximately US$7.4 billion, according to research produced byVenture Intelligence, India. - Ends- About Evolvence India Holding (EIH): EIH is promoted by Evolvence Capital Ltd ("Evolvence Capital"), a Dubai based,B.V.I. incorporated, alternative investment firm established in 2000 with aprimary investment focus on Gulf Co-operation Council countries and India.Evolvence Capital currently has assets under management of approximately US$ onebillion. EIH is an Isle of Man incorporated, private equity fund of fundsholding company focused on India. For more information, please contact: Shilpa MathaiCommunications ManagerEvolvence Capital1101 API Tower, Sheikh Zayed RoadDubai, UAE Tel: +971 4 332 4033Mob: + 97150 346 3979Email: shilpa@evolvence.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th May 202011:49 amRNSResult of EGM and Notice of Cancellation
7th Apr 20207:00 amRNSProposed AIM Cancellation and Notice of EGM
2nd Apr 20205:38 pmRNSReturn of Capital and COVID-19 Update
6th Dec 20197:00 amRNSReturn of Capital
29th Nov 20197:00 amRNSDelisting Update
21st Nov 20197:00 amRNSMarket Update
30th Sep 20194:30 pmRNSInterim Results
30th Jul 201911:15 amRNSResult of AGM
28th Jun 20197:00 amRNSPosting of 2018 Annual Results and Notice of AGM
24th May 20195:53 pmRNSHolding(s) in Company
1st May 20197:00 amRNSReturn of Capital
4th Apr 20195:00 pmRNSSale of RSB and Return of Capital
25th Jan 20197:00 amRNSHolding(s) in Company
21st Jan 20196:13 pmRNSHolding(s) in Company
18th Jan 201911:37 amRNSHolding(s) in Company
28th Sep 20187:00 amRNSInterim Results
26th Jul 201811:05 amRNSResult of AGM
28th Jun 20187:00 amRNSPosting of 2017 Annual Report and Notice of AGM
28th Jun 20187:00 amRNSReturn of Capital
20th Mar 20181:00 pmRNSReplacement: Return of Capital
20th Mar 20187:00 amRNSReturn of Capital
29th Sep 20175:17 pmRNSHalf-year Report
29th Sep 20175:13 pmRNSReturn of capital
24th Jul 201710:54 amRNSResults of Annual General Meeting
26th Jun 20176:01 pmRNSDirectorate Change
26th Jun 20176:00 pmRNSPosting of 2016 Annual Report and Notice of AGM
9th Feb 20178:05 amRNSReturn of Capital
26th Jan 20175:08 pmRNSHolding(s) in Company
25th Jan 20179:30 amRNSHolding(s) in Company
5th Jan 20177:00 amRNSUpdate re EIF
30th Sep 20167:00 amRNSHalf-year Report
25th Jul 20161:24 pmRNSResult of AGM
27th Jun 20165:37 pmRNSPosting of Annual Report & Notice of AGM
27th Jun 20167:00 amRNSFinal Results
27th Jun 20167:00 amRNSReturn of Capital
30th Nov 20155:57 pmRNSHolding(s) in Company
30th Sep 20157:00 amRNSInterim Results
30th Jun 201511:53 amRNSResult of AGM
9th Jun 20154:00 pmRNSNotice of AGM
5th Jun 20154:35 pmRNSFinal Results
30th Sep 20147:00 amRNSHalf Yearly Report
14th Jul 20143:19 pmRNSReturn of Capital
30th Jun 201411:57 amRNSResult of AGM
4th Jun 20147:00 amRNSNotice of AGM
3rd Jun 20147:00 amRNSFinal Results
3rd Dec 201311:16 amRNSHolding(s) in Company
2nd Dec 20134:09 pmRNSHolding(s) in Company
28th Nov 20135:14 pmRNSHolding(s) in Company
27th Nov 20133:14 pmRNSSale of Interest in Gland Pharma Limited
22nd Nov 20139:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.